Drug Safety Update
Published 17 December 2020
From: Medicines and Healthcare products Regulatory Agency
Erythromycin has been associated with events secondary to QT interval prolongation such as cardiac arrest and ventricular fibrillation.
Published 17 December 2020
From: Medicines and Healthcare products Regulatory Agency
Erythromycin has been associated with events secondary to QT interval prolongation such as cardiac arrest and ventricular fibrillation.